TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03405194

Same-Day Treatment With Genvoya vs. EFV/TDF/3TC

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“Haiti gained access to dolutegravir as first-line ART, so we cancelled the study before any patient was enrolled (we didn't want SOC group to receive EFV)”

The sponsor’s own words in the registry.

Life of this trial

20172018201920202021Registered2017-12-24Planned start2018-05-01 (planned)Withdrawn (as of)2020-03-18

Vital statistics

Status
Withdrawn
Phase
Na
Sponsor
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Sponsor type
University, hospital or other
Conditions
HIV/AIDS
Interventions
Elvitegravir, Cobicistat, TAF, FTC; Efavirenz, TDF, and 3TC
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.